Metabolic pathways in obesity-related breast cancer.
Kristy A BrownPublished in: Nature reviews. Endocrinology (2021)
This Review focuses on the mechanistic evidence for a link between obesity, dysregulated cellular metabolism and breast cancer. Strong evidence now links obesity with the development of 13 different types of cancer, including oestrogen receptor-positive breast cancer in postmenopausal women. A number of local and systemic changes are hypothesized to support this relationship, including increased circulating levels of insulin and glucose as well as adipose tissue-derived oestrogens, adipokines and inflammatory mediators. Metabolic pathways of energy production and utilization are dysregulated in tumour cells and this dysregulation is a newly accepted hallmark of cancer. Dysregulated metabolism is also hypothesized to be a feature of non-neoplastic cells in the tumour microenvironment. Obesity-associated factors regulate metabolic pathways in both breast cancer cells and cells in the breast microenvironment, which provides a molecular link between obesity and breast cancer. Consequently, interventions that target these pathways might provide a benefit in postmenopausal women and individuals with obesity, a population at high risk of breast cancer.
Keyphrases
- postmenopausal women
- insulin resistance
- type diabetes
- metabolic syndrome
- weight loss
- high fat diet induced
- induced apoptosis
- weight gain
- adipose tissue
- bone mineral density
- cell cycle arrest
- positive breast cancer
- high fat diet
- machine learning
- signaling pathway
- skeletal muscle
- oxidative stress
- stem cells
- blood glucose